ESG Report 2024

38 Provisions on the Administration of Pharmaceutical Directions and Labels Pharmaceutical Description and Labelling Product Manual Modification Management Procedure Product Manual Acceptance Standards Product Label Acceptance Standards The Group has formulated strict internal policies, stipulating that pharmaceutical labels and package inserts must meet relevant requirements. Pharmaceutical labels must itemise the drug name, ingredients, use of drug, directions and dosage, production date and other relevant information to let users understand the usage and risks of the pharmaceuticals. Besides, the Group also formulates requirements for packaging labels on transportation, storage use and active pharmaceutical ingredients. For example, such packaging labels must indicate the pharmaceutical name, number of packages, expiration date, storage and transportation precautions and other necessary information to avoid incidents affecting drug quality due to improper transportation and storage. Moreover, package inserts must contain details of the pharmaceutical's directions, data and information showing its safety, effectiveness and adverse drug reactions, so as to guide users to take the pharmaceuticals correctly and reasonably. The Group will constantly monitor the use of the pharmaceuticals, and will submit applications to the National Medical Products Administration to amend package inserts when necessary, so as to provide users with the best pharmaceutical information and description. At the same time, the Group has also set up management procedures for plate making, printing, and acceptance of product labels, manuals, and printed packaging materials. The Quality Management Department will carry out acceptance and inspection work at every step, from the drafting, sample printing to printing of product labels, manuals and packaging materials. This ensures that all the materials will be put into the factories for use without errors, and minimises the possibility of product quality problems caused by printing errors. 7.2 Product Marketing and Promotion Pharmaceutical sale is a key sector of the Group's business, while requirements for pharmaceutical promotion information are much higher and more stringent than those of general commodities. In light of this, the Group regulates the distribution and promotion of pharmaceuticals in strict accordance with relevant laws and regulations. Advertising Law of the People’s Republic of China Standards for the Examination and Publication of Drug Advertisements Measures for the Examination of Drug Advertisements Product Marketing and Promotion Compliance Department Unannounced Inspection Process (Marketing Promotion Category) Sales Code of Conduct Compliance Promotion Guidelines Regulation on Registration, Review, and Management Policy for Pharmaceutical Representatives Compliance Unannounced Inspection Policy Compliance Incident Reporting Policy The Group has formulated relevant systems that clearly enumerate the Group's advertising requirements, application procedures of advertisement and promotion data feed, precautions for use, etc. All pharmaceutical promotion information released by the Group is based on scientific evidence, complies with the principles of accuracy, objectivity, and completeness, and contains corresponding package inserts to clarify the correct medication methods. All these comply with legal requirements. In order to ensure that the Group's advertisements comply with relevant laws and regulations, the samples of the advertising materials must be submitted to the Group's Legal Affairs Centre for systematically audit before being released. 7.2.1 Promotion Environmental, Social and Governance Report 2024 The United Laboratories International Holdings Limited Aspects Relevant Laws, Regulations and Guidelines Internal Policies Aspects Relevant Laws, Regulations and Guidelines Internal Policies